IDEXX LABORATORIES INC /DE Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31)
IDEXX LABORATORIES INC /DE (IDXX) reported Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) of 230.00% for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-04-20.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition · last filed 2012-04-20
- IDEXX LABORATORIES INC /DE employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition (deprecated 2012-01-31) for the quarter ending 2012-03-31 was 230.00%.
- IDEXX LABORATORIES INC /DE employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition (deprecated 2012-01-31) for fiscal 2011 was 170.00%.
| Period end | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 3 month | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 6 month | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 9 month | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | 230.00% 10-Q · filed 2012-04-20 | |||
| 2011-12-31 | 170.00% 10-K · filed 2012-02-17 | |||
| 2011-09-30 | 190.00% 10-Q · filed 2011-10-21 | |||
| 2011-06-30 | 210.00% 10-Q · filed 2011-07-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |